Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| Yesterday 6:52 PM View:  | Kurtoglu Metin Chief Technology Officer | Cartesian Therapeutics, Inc. (RNAC) | Yesterday | Option Exercise | 32,789 | $1.41 | $46,232.50 | 64% 51.03K to 83.82K | |
| Yesterday 6:52 PM View: | Kurtoglu Metin Chief Technology Officer | Cartesian Therapeutics, Inc. (RNAC) | Yesterday | Option Sale | 32,789 | $16.67 | $546,560.00 | (39%) 83.82K to 51.03K | |
| Yesterday 6:50 PM View: | Jewell Christopher M Chief Scientific Officer | Cartesian Therapeutics, Inc. (RNAC) | 20-Nov-24 | Option Exercise | 14,000 | $3.23 | $45,220.00 | 54% 25.94K to 39.94K | |
| Yesterday 6:52 PM View: | Kurtoglu Metin Chief Technology Officer | Cartesian Therapeutics, Inc. (RNAC) | 20-Nov-24 | Option Exercise | 5,700 | $1.41 | $8,037.00 | 11% 51.03K to 56.73K | |
| Yesterday 6:52 PM View: | Kurtoglu Metin Chief Technology Officer | Cartesian Therapeutics, Inc. (RNAC) | 20-Nov-24 | Option Sale | 5,700 | $17.29 | $98,569.70 | (10%) 56.73K to 51.03K | |
| Yesterday 6:51 PM View: | Singer Michael Director | Cartesian Therapeutics, Inc. (RNAC) | 19-Nov-24 | Gift | 28,821 | -- | -- | (4%) 774.62K to 745.8K | |
| Yesterday 6:52 PM View: | Kurtoglu Metin Chief Technology Officer | Cartesian Therapeutics, Inc. (RNAC) | 19-Nov-24 | Option Exercise | 200 | $1.41 | $282.00 | < 1% 51.03K to 51.23K | |
| Yesterday 6:52 PM View: | Kurtoglu Metin Chief Technology Officer | Cartesian Therapeutics, Inc. (RNAC) | 19-Nov-24 | Option Sale | 200 | $19.50 | $3,900.00 | (< 1%) 51.23K to 51.03K | |
| 18-Nov-24 7:32 PM View: | Kurtoglu Metin Chief Technology Officer | Cartesian Therapeutics, Inc. (RNAC) | 18-Nov-24 | Option Exercise | 34,400 | $1.41 | $48,504.00 | 67% 51.03K to 85.43K | |
| 18-Nov-24 7:32 PM View: | Kurtoglu Metin Chief Technology Officer | Cartesian Therapeutics, Inc. (RNAC) | 18-Nov-24 | Option Sale | 34,400 | $18.39 | $632,641.00 | (40%) 85.43K to 51.03K | |
| 18-Nov-24 7:35 PM View: | Springer Timothy A Director 10% Owner | Cartesian Therapeutics, Inc. (RNAC) | 18-Nov-24 | Purchase | 58,295 | $18.12 | $1,056,180.00 | < 1% 9.26M to 9.32M | |
| 18-Nov-24 7:23 PM View: | Jewell Christopher M Chief Scientific Officer | Cartesian Therapeutics, Inc. (RNAC) | 15-Nov-24 | Option Exercise | 16,065 | $3.23 | $51,889.90 | 62% 25.94K to 42.01K | |
| 18-Nov-24 7:23 PM View: | Jewell Christopher M Chief Scientific Officer | Cartesian Therapeutics, Inc. (RNAC) | 15-Nov-24 | Option Sale | 16,065 | $17.06 | $274,093.00 | (38%) 42.01K to 25.94K | |
| 18-Nov-24 7:28 PM View: | Miljkovic Milos Chief Medical Officer | Cartesian Therapeutics, Inc. (RNAC) | 15-Nov-24 | Option Exercise | 20,000 | $3.23 | $64,600.00 | 109% 18.27K to 38.27K | |
| 18-Nov-24 7:35 PM View: | Springer Timothy A Director 10% Owner | Cartesian Therapeutics, Inc. (RNAC) | 15-Nov-24 | Purchase | 277,246 | $17.09 | $4,739,190.00 | 3% 8.98M to 9.26M | |
| 18-Nov-24 7:32 PM View: | Kurtoglu Metin Chief Technology Officer | Cartesian Therapeutics, Inc. (RNAC) | 15-Nov-24 | Option Exercise | 22,068 | $1.41 | $31,115.90 | 43% 51.03K to 73.1K | |
| 18-Nov-24 7:32 PM View: | Kurtoglu Metin Chief Technology Officer | Cartesian Therapeutics, Inc. (RNAC) | 15-Nov-24 | Option Sale | 22,068 | $17.20 | $379,497.00 | (30%) 73.1K to 51.03K | |
| 18-Nov-24 7:28 PM View: | Miljkovic Milos Chief Medical Officer | Cartesian Therapeutics, Inc. (RNAC) | 15-Nov-24 | Option Sale | 20,000 | $17.14 | $342,888.00 | (52%) 38.27K to 18.27K | |
| 18-Nov-24 7:35 PM View: | Springer Timothy A Director 10% Owner | Cartesian Therapeutics, Inc. (RNAC) | 14-Nov-24 | Purchase | 96,399 | $16.37 | $1,578,160.00 | 1% 8.88M to 8.98M | |
| 18-Nov-24 7:32 PM View: | Kurtoglu Metin Chief Technology Officer | Cartesian Therapeutics, Inc. (RNAC) | 14-Nov-24 | Option Exercise | 25,900 | $1.41 | $36,519.00 | 51% 51.03K to 76.93K | |
| 18-Nov-24 7:32 PM View: | Kurtoglu Metin Chief Technology Officer | Cartesian Therapeutics, Inc. (RNAC) | 14-Nov-24 | Option Sale | 25,900 | $16.44 | $425,900.00 | (34%) 76.93K to 51.03K | |
| 18-Nov-24 7:28 PM View: | Miljkovic Milos Chief Medical Officer | Cartesian Therapeutics, Inc. (RNAC) | 14-Nov-24 | Option Sale | 35,000 | $16.13 | $564,644.00 | (66%) 53.27K to 18.27K | |
| 18-Nov-24 7:23 PM View: | Jewell Christopher M Chief Scientific Officer | Cartesian Therapeutics, Inc. (RNAC) | 14-Nov-24 | Option Exercise | 36,050 | $3.23 | $116,442.00 | 139% 25.94K to 61.99K | |
| 18-Nov-24 7:23 PM View: | Jewell Christopher M Chief Scientific Officer | Cartesian Therapeutics, Inc. (RNAC) | 14-Nov-24 | Option Sale | 36,050 | $16.67 | $600,949.00 | (58%) 61.99K to 25.94K | |
| 18-Nov-24 7:28 PM View: | Miljkovic Milos Chief Medical Officer | Cartesian Therapeutics, Inc. (RNAC) | 14-Nov-24 | Option Exercise | 35,000 | $3.23 | $113,050.00 | 192% 18.27K to 53.27K | |
| 15-Oct-24 4:53 PM View: | Kalayoglu Murat Director 10% Owner | Cartesian Therapeutics, Inc. (RNAC) | 11-Oct-24 | Option Exercise | 1,518,370 | -- | -- | 43% 3.54M to 5.06M | |
| 15-Oct-24 4:43 PM View: | Hoge Elizabeth 10% Owner | Cartesian Therapeutics, Inc. (RNAC) | 11-Oct-24 | Option Exercise Duplicate | 1,518,370 | -- | -- | 43% 3.54M to 5.06M | |
| 04-Oct-24 5:58 PM View: | Springer Timothy A Director 10% Owner | Cartesian Therapeutics, Inc. (RNAC) | 04-Oct-24 | Purchase | 80,301 | $22.58 | $1,813,010.00 | < 1% 8.8M to 8.88M | |
| 04-Oct-24 5:58 PM View: | Springer Timothy A Director 10% Owner | Cartesian Therapeutics, Inc. (RNAC) | 03-Oct-24 | Purchase | 119,906 | $19.89 | $2,384,710.00 | 1% 8.68M to 8.8M | |
| 04-Oct-24 5:58 PM View: | Springer Timothy A Director 10% Owner | Cartesian Therapeutics, Inc. (RNAC) | 02-Oct-24 | Acquisition (other) | 317,879 | -- | -- | 3% 10.48M to 10.8M | |
| 04-Oct-24 5:58 PM View: | Springer Timothy A Director 10% Owner | Cartesian Therapeutics, Inc. (RNAC) | 02-Oct-24 | Purchase | 5,514 | $17.38 | $95,821.70 | < 1% 10.8M to 10.8M | |
| 04-Oct-24 5:58 PM View: | Springer Timothy A Director 10% Owner | Cartesian Therapeutics, Inc. (RNAC) | 02-Oct-24 | Disposition (other) | 2,119,190 | -- | -- | (20%) 10.8M to 8.68M | |
| 04-Oct-24 5:58 PM View: | Springer Timothy A Director 10% Owner | Cartesian Therapeutics, Inc. (RNAC) | 02-Oct-24 | Acquisition (other) | 1,801,310 | -- | -- | 21% 8.68M to 10.48M | |
| 27-Sep-24 4:13 PM View: | Springer Timothy A Director 10% Owner | Cartesian Therapeutics, Inc. (RNAC) | 25-Sep-24 | Option Exercise | 722,668 | -- | -- | 7% 10.32M to 11.04M | |
| 27-Sep-24 4:13 PM View: | Springer Timothy A Director 10% Owner | Cartesian Therapeutics, Inc. (RNAC) | 25-Sep-24 | Option Exercise | 1,636,830 | -- | -- | (15%) 11.04M to 9.4M | |
| 27-Sep-24 4:13 PM View: | Springer Timothy A Director 10% Owner | Cartesian Therapeutics, Inc. (RNAC) | 25-Sep-24 | Option Exercise | 1,636,830 | -- | -- | 19% 8.68M to 10.32M | |
| 27-Sep-24 4:13 PM View: | Springer Timothy A Director 10% Owner | Cartesian Therapeutics, Inc. (RNAC) | 25-Sep-24 | Option Exercise | 722,668 | -- | -- | (8%) 9.4M to 8.68M | |
| 14-Aug-24 4:43 PM View: | Springer Timothy A Director 10% Owner | Cartesian Therapeutics, Inc. (RNAC) | 12-Aug-24 | Purchase | 8,016 | $12.72 | $101,968.00 | < 1% 6.31M to 6.32M | |
| 14-Aug-24 4:41 PM View: | Barabe Timothy C Director | Cartesian Therapeutics, Inc. (RNAC) | 12-Aug-24 | Purchase | 7,500 | $12.70 | $95,250.00 | 53% 14.27K to 21.77K | |
| 05-Jul-24 4:02 PM View: | Springer Timothy A Director 10% Owner | Cartesian Therapeutics, Inc. (RNAC) | 02-Jul-24 | Grant | 1,636,830 | $20.00 | $32,736,600.00 | 26% 6.31M to 7.95M | |
| 05-Jul-24 4:02 PM View: | Springer Timothy A Director 10% Owner | Cartesian Therapeutics, Inc. (RNAC) | 02-Jul-24 | Grant | 722,668 | $20.00 | $14,453,400.00 | 9% 7.95M to 8.67M | |
| 03-Jul-24 4:10 PM View: | Malik Kemal Director | Cartesian Therapeutics, Inc. (RNAC) | 01-Jul-24 | Grant | 5,933 | -- | -- | 100% 0 to 5.93K | |
| 10-Apr-24 9:40 PM View: | Springer Timothy A Director 10% Owner | Cartesian Therapeutics, Inc. (RNAC) | 08-Apr-24 | Option Exercise | 826,169 | -- | -- | 15% 5.63M to 6.46M | |
| 10-Apr-24 9:43 PM View: | Kalayoglu Murat Director 10% Owner | Cartesian Therapeutics, Inc. (RNAC) | 08-Apr-24 | Option Exercise | 491,853 | -- | -- | 395% 124.65K to 616.5K | |
| 10-Apr-24 4:20 PM View: | Hoge Elizabeth 10% Owner | Cartesian Therapeutics, Inc. (RNAC) | 08-Apr-24 | Conversion | 3,418,620 | -- | -- | 2743% 124.64K to 3.54M | |
| 10-Apr-24 9:40 PM View: | Springer Timothy A Director 10% Owner | Cartesian Therapeutics, Inc. (RNAC) | 08-Apr-24 | Option Exercise | 123,925 | -- | -- | (2%) 6.46M to 6.34M | |
| 10-Apr-24 9:47 PM View: | Singer Michael Director | Cartesian Therapeutics, Inc. (RNAC) | 08-Apr-24 | Option Exercise | 110,151 | -- | -- | 529% 20.84K to 130.99K | |
| 10-Apr-24 9:43 PM View: | Kalayoglu Murat Director 10% Owner | Cartesian Therapeutics, Inc. (RNAC) | 08-Apr-24 | Option Exercise | 2,926,760 | -- | -- | 475% 616.5K to 3.54M | |
| 10-Apr-24 9:40 PM View: | Springer Timothy A Director 10% Owner | Cartesian Therapeutics, Inc. (RNAC) | 08-Apr-24 | Option Exercise | 4,130,850 | -- | -- | 275% 1.5M to 5.63M | |
| 10-Apr-24 9:40 PM View: | Springer Timothy A Director 10% Owner | Cartesian Therapeutics, Inc. (RNAC) | 08-Apr-24 | Option Exercise | 24,785 | -- | -- | (< 1%) 6.34M to 6.31M |
